Compounds > dexmedetomidine
Page last updated: 2024-08-24

dexmedetomidine and Cardiac Hypertrophy

dexmedetomidine has been researched along with Cardiac Hypertrophy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Du, J; Gu, M; Li, C; Li, S; Li, W; Liu, H; Sun, Q; Weng, X; Xu, Y; Zhang, X1
Hirata, N; Kawaguchi, R; Tokinaga, Y; Yamakage, M; Yoshikawa, Y1

Other Studies

2 other study(ies) available for dexmedetomidine and Cardiac Hypertrophy

ArticleYear
An α
    International journal of medical sciences, 2020, Volume: 17, Issue:16

    Topics: Adrenergic alpha-2 Receptor Agonists; AMP-Activated Protein Kinases; Animals; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Cardiomegaly; Cells, Cultured; Dexmedetomidine; Disease Models, Animal; Drug Evaluation, Preclinical; Heart Failure; Humans; Male; Membrane Potential, Mitochondrial; Mice; Mitochondria; Myocytes, Cardiac; Primary Cell Culture; Rats; Signal Transduction

2020
Dexmedetomidine Maintains Its Direct Cardioprotective Effect Against Ischemia/Reperfusion Injury in Hypertensive Hypertrophied Myocardium.
    Anesthesia and analgesia, 2018, Volume: 126, Issue:2

    Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Cardiomegaly; Cardiotonic Agents; Dexmedetomidine; Hypertension; Male; Myocardial Reperfusion Injury; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Treatment Outcome

2018